NeuroQore offers a novel form of rTMS with an enhanced pulse, with personalized targeting, and post-treatment brain assessments.
NeuroQore has raised $1.5M in total funding. The most recent round was Undisclosed. The last funding was announced in September 2025.
NeuroQore's investors include SOSV, SOSV SF & NY (Fka IndieBio), Ontario Brain Institute.
NeuroQore is headquartered in San Francisco, United States.
NeuroQore offers a novel form of rTMS with an enhanced pulse, with personalized targeting, and post-treatment brain assessments.
NeuroQore is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NeuroQore — Funding & Investors." VCBacked, September 26, 2025, https://www.vcbacked.co/company/neuroqore. Accessed August 15, 2026.
VCBacked. (2025). NeuroQore — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/neuroqore
{{cite web |title=NeuroQore — Funding & Investors |url=https://www.vcbacked.co/company/neuroqore |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated